Explore the compound
Quick Facts
Mechanism of Action
PT-141, also known as bremelanotide, is a melanocortin-receptor agonist peptide. Its mechanism acts centrally through melanocortin pathways connected to sexual-arousal signaling.
Mechanism of Action: acts centrally through melanocortin pathways connected to sexual-arousal signaling.
- Supports sexual-desire pathways through melanocortin receptor activity [1].
- Clinical literature documents use of bremelanotide/PT-141 in hypoactive sexual desire disorder research [1].
- Acts centrally rather than through vascular-only mechanisms, making it distinct from PDE5-style approaches [1].
- Official medical databases include trial and drug-information records for this pathway [2][5].
Research Applications & Context
Community-reported protocol schedules.
Research Dosage Information
Reported research quantities and their source context. These are not recommendations, and source status varies.
Scroll the table horizontally to read every column. Select a row to inspect it in the calculator.
Weeks 1-8: 500mcg Once daily. Weeks 1-8. Weeks 9-12: 1000mcg Once daily. Weeks 9-12. Weeks 13-16: 1500mcg Once daily. Weeks 13-16.
| Phase | Reported Amount | Frequency | Draw Units | Cycle | Notes | Calculator |
|---|---|---|---|---|---|---|
| Weeks 1-8 | 500mcg | Once daily | Select a vial | Weeks 1-8 | Community-reported protocol. | |
| Weeks 9-12 | 1000mcg | Once daily | Select a vial | Weeks 9-12 | Community-reported protocol. | |
| Weeks 13-16 | 1500mcg | Once daily | Select a vial | Weeks 13-16 | Community-reported protocol. |
Dosing Protocol & Schedule
Community-reported research schedules, not clinically validated protocols. Select a reported scenario and duration to calculate mathematical quantities.
| Period | Research Dose | Frequency | Total Injections | Total amount | Volume per entry | U-100 equivalent |
|---|
Strength changes affect volume and supplies, not the underlying community-reported quantities. Figures exceeding the selected syringe capacity are flagged; they are not instructions for splitting administrations.
Plan a Regimen Schedule
Save the selected research protocol to your private calendar. Scheduled entries never create Dose Logs.
Reconstitution Calculator
Select the vial strength you are examining. The reference chart displays examples, not recommended preparation volumes or validated protocols.
Reconstitution Reference Chart
Hypothetical volume comparisons for the selected vial. No particular volume is endorsed, and vial capacity, solubility, excipients and product-specific instructions are not established by this table.
| Example volume | Calculated concentration | Calculator |
|---|---|---|
| 1 mL | — | |
| 2 mL | — | |
| 3 mL | — | |
| 4 mL | — | |
| 5 mL | — |
Choose a compatible dry vial to see reference concentrations.
Research-only mathematical comparisons; not instructions to compound, prepare, or administer peptides. Community-reported protocols are not clinically validated by inclusion here.
Supplies Needed — Estimate
Select a vial strength and an example reconstitution volume below. Counts use only the checked, computable rows above; they are not product-specific sterility, compatibility, or stability guidance.
Select a compatible vial and volume below to view quantities.
Educational and entertainment purposes only. Research use only; not for human or animal administration. Pad counts assume two per Total entry; syringe counts include additional containers where a single entry exceeds the selected syringe capacity. Vial totals assume full theoretical recovery and do not account for dead volume, spoilage, asepsis, expiration, potency, route, or beyond-use dating. These figures are not a recommended supplies list for an actual procedure.
Published References (0 identified)
A recorded identifier identifies a publication; it does not establish that its claims have been independently verified.
Research indexes & other source links
Searches, registries and unverified source records are discovery resources, not verified published studies.
- PubMed.gov biomedical literature: PT-141 View source ↗ PubMed index/search · Source link recorded; claim verification separate
- ClinicalTrials.gov study registry: PT-141 View source ↗ ClinicalTrials.gov registry/search · Source link recorded; claim verification separate
- NIH/NCBI all-databases search: PT-141 View source ↗ NCBI database/search · Source link recorded; claim verification separate
- PubChem / NIH compound record search: PT-141 View source ↗ PubChem database/search · Source link recorded; claim verification separate
Peptide Research Collection Library